Primary malignant liver tumor including hepatocellular carcinoma, intrahepatic bile duct cancer, combined hepatocellular-cholangiocarcinoma. Metastatic liver tumor.
Conditions
Interventions
In the intervention group, the liver transection is performed using LigaSure.
In the intervention group, the liver transection is performed using Harmonic.
In the control group, the liver transection
Sponsors
Hepato-biliary-pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo
Department of Gastrointestinal Surgery, Nihon University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients who will undergo hepatic resection for malignant liver tumor 2)ECOG Performance Status 0-2 3)Patients who meet the Makuuchi criteria
Exclusion criteria
Exclusion criteria: 1)Donor of liver transplantation 2)Patients who will undergo biliary tract reconstruction 3)Patients who will undergo resection of the gastrointestinal tract at the same time 4)Patients with simultaneous double cancer 5)When the clamping of hepatoduodenal ligament is expected to be difficult 6)Possibility of exploratory laparotomy 7)Patients with severe complications 8)Patients who were deemed inappropriate for medical reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of bleeding during liver transection | — |
Secondary
| Measure | Time frame |
|---|---|
| Total transection time, Cross-sectional area per minute, Operative duration, Postoperative complications, Postoperative liver function, Length of hospital stay | — |
Countries
Japan
Contacts
Public ContactAkihiko Ichida, Kiyoshi Hasegawa
The University of Tokyo Hepato-biliary-pnacreatic Surgery Division, Department of Surgery, Graduate School of Medicine
Outcome results
None listed